HAOHAI BIOTEC (06826): Completed Repurchase of 1.8324 Million A-Shares

Stock News
08/15

HAOHAI BIOTEC (06826) announced the results of its second phase A-share repurchase program. As of August 14, 2025, the company has completed the current repurchase phase. Through the Shanghai Stock Exchange's centralized bidding trading system, the company has cumulatively repurchased 1.8324 million A-shares, representing 0.79% of the company's total share capital. The highest transaction price during the repurchase was 63.58 yuan per share, while the lowest price was 49.25 yuan per share, with an average repurchase price of 56.70 yuan per share. The total amount paid reached 103.9 million yuan (excluding stamp duty, transaction commissions and other fees).

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10